Foundation Leadership

Jason Menzo is the Chief Executive Officer of the Foundation Fighting Blindness, the global leading organization driving the discovery, development, and delivery of treatments and cures for people affected by blinding retinal diseases. To date, the Foundation has raised nearly $1 billion and currently supports more than 100 active research programs worldwide, while advancing and influencing 50+ clinical trials across the global retinal disease landscape — accelerating the path from scientific discovery to patients.

Under Jason’s leadership, the Foundation has strengthened its role as a field-shaping organization, aligning philanthropy, science, and investment to drive progress. He co-launched the RD Fund, the Foundation’s venture philanthropy arm, serves on its management team, and supports strategies that translate scientific breakthroughs into sustainable, patient-ready therapies. His leadership emphasizes disciplined stewardship, transparency, and long-term impact to ensure philanthropic capital is deployed responsibly and effectively in service of the mission.

In addition to his role at the Foundation, Jason serves on the board of Retina International, a global alliance of patient-led organizations spanning more than 40 countries, advancing collaboration across research, advocacy, and policy. He is also a co-founder of Opus Genetics, a clinical-stage gene therapy company focused on inherited retinal diseases.

Prior to joining the Foundation Fighting Blindness, Jason was Business Unit Head at Sun Ophthalmics, where he was one of four founding team members and was instrumental in building the organization from inception into a global leading ophthalmic company. Earlier in his career, he was a founding member of Nicox, Inc., led the commercial launch of multiple ophthalmic brands, and held roles of increasing responsibility at Bausch + Lomb and Inspire Pharmaceuticals.